The promise of combining radiation therapy and immunotherapy: Morbidity and toxicity

Future Oncology

Volumn 10, Issue 15, 2014, Pages 2319-2328

  Agassi, Andre M ^a   Myslicki, Francisco A ^a   Shulman, Jesse M ^a   Rotterman, Yosef ^a   Dosoretz, Daniel E ^a   Fernandez, Eduardo ^a   Mantz, Constantine A ^a   Finkelstein, Steven E ^a  

^a 21ST CENTURY ONCOLOGY   (United States)

Author keywords

immunotherapy; radiation; radiation oncology; radiation therapy; radiotherapy

Indexed keywords

ALPHA2B INTERFERON; IPILIMUMAB; LC 9018; POXVIRUS VACCINE; RECOMBINANT INTERLEUKIN 2; TOLL LIKE RECEPTOR 9 AGONIST; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG; VACCINIA VACCINE; VIRUS VACCINE;

ANOREXIA; ARTHRALGIA; ARTHROPATHY; ARTICLE; B CELL LYMPHOMA; CANCER CELL; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; DENDRITIC CELL; DIARRHEA; ELECTROLYTE DISTURBANCE; ERYTHEMA; EXTERNAL BEAM RADIOTHERAPY; FATIGUE; FEVER; FIBROSIS; FLU LIKE SYNDROME; HUMAN; HYPERGLYCEMIA; HYPOTENSION; HYPOXEMIA; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOSTIMULATION; INJECTION SITE ERYTHEMA; INJECTION SITE INDURATION; INJECTION SITE PAIN; INJECTION SITE REACTION; INJECTION SITE SWELLING; KIDNEY CARCINOMA; LACTOBACILLUS CASEI; LYMPH NODE METASTASIS; LYMPHEDEMA; LYMPHOCYTOPENIA; MELANOMA; MENTAL DISEASE; METASTATIC MELANOMA; MORBIDITY; MULTIMODALITY CANCER THERAPY; MYALGIA; MYCOSIS FUNGOIDES; NAUSEA; NONHUMAN; PERIPHERAL NEUROPATHY; PROSTATE CANCER; PRURITUS; RADIATION DOSE FRACTIONATION; RIGOR; SKIN NECROSIS; SKIN TOXICITY; SOFT TISSUE SARCOMA; STEREOTACTIC BODY RADIATION THERAPY; TELANGIECTASIA; TREATMENT OUTCOME; UREMIA; UTERINE CERVIX CARCINOMA; WHOLE BODY RADIATION;

EID: 84920045802     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.14.188     Document Type: Article

References (35)

1. Finkelstein SE, Fishman M. Current status of sipuleucel-T for the treatment of asymptomatic or minimally symptomatic metastatic castration-resistant (hormone-refractory) prostate cancer. Int. J. Clin. Rev. doi:10.5275/ijcr.2011.12.10 (2011).
2. Finkelstein SE, Fishman M. Clinical opportunities in combining immunotherapy with radiation therapy. Front. Oncol. 2, 169 (2012).
3. Lugade AA, Sorensen EW, Gerber SA et al. Radiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunity. J. Immunol. 180(5), 3132-3139 (2008).
4. Finkelstein SE, Timmerman R, McBride WH et al. The confluence of stereotactic ablative radiotherapy and tumor immunology. Clin. Dev. Immunol. 439752 (2011).
5. Okwan-Duodu D, Pollack BP, Lawson D et al. Role of radiation therapy as immune activator in the era of modern immunotherapy for metastatic malignant melanoma. Am. J. Clin. Oncol. doi:10.1097/ COC.0b013e3182940dc3 (2014) (Epub ahead of print).
6. Zeng J, See AP, Phallen J et al. Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas. Int. J. Radiat. Oncol. Biol. Phys. 86, 343-349 (2013).
7. Lee Y, Auh SL, Wang Y et al. Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood 114(3), 589-595 (2009).
8. Takeshima T, Chamoto K, Wakita D et al. Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapy. Cancer Res. 70(7), 2697-2706 (2010).
9. Ferrara TA, Hodge JW, Gulley JL. Combining radiation and immunotherapy for synergistic antitumor therapy. Curr. Opin. Mol. Ther. 11(1), 37-42 (2009).
10. Formenti SC, Demaria S. Combining radiotherapy and cancer immunotherapy: a paradigm shift. J. Natl Cancer Inst. 105, 256-265 (2013).
11. Finkelstein SE, Rodriguez F, Dunn M et al. Serial assessment of lymphocytes and apoptosis in the prostate during coordinated intraprostatic dendritic cell injection and radiotherapy. Immunotherapy 4, 373-382 (2012).
12. Nagorsen D, Panelli M, Dudley ME, Finkelstein SE, Rosenberg SA, Marincola FM. Biased epitope selection by recombinant vaccinia-virus(rVV)-infected mature or immature dendritic cells. Gene Ther. 10, 1754-1765 (2003).
13. Overwijk WW, Theoret MR, Finkelstein SE et al. Tumor regression and autoimmunity following reversal of a functionally tolerant state of self-reactive CD8+ T cells. J. Exp. Med. 198, 569-580 (2003).
14. Finkelstein SE, Heimann DM, Klebanoff CA et al. Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancer. J. Leukoc. Biol. 76, 333-337 (2004).
15. Klebanoff CA, Finkelstein SE, Surman DR et al. IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells. Proc. Natl Acad. Sci. USA 101, 1969-1974 (2004).
16. Kakinuma T, Nadiminti H, Lonsdorf AS et al. Small numbers of residual tumor cells at the site of primary inoculation are critical for anti-tumor immunity following challenge at a secondary location. Cancer Immunol. Immunother. 56, 1119-1131 (2007).
17. Kingsley DP. An interesting case of possible abscopal effect in malignant melanoma. Br. J. Radiol. 48, 863-866 (1975).
18. Postow MA, Callahan MK, Barker CA et al. Immunologic correlates of the abscopal effect in a patient with melanoma. N. Engl. J. Med. 366, 925-931 (2012).
19. Stamell EF, Wolchok JD, Gnjatic S, Lee NY, Brownell I. The abscopal effect associated with asystemic anti-melanoma immune response. Int. J. Radiat. Oncol. Biol. Phys. 85, 293-295 (2012).
20. Kalbasi A, June CH, Haas N, Vapiwala N. Radiation and immunotherapy: a synergistic combination. J. Clin. Invest. 123, 2756-2763 (2013).
21. Barker CA, Postow MA. Combinations of radiation therapy and immunotherapy for melanoma: a review of clinical outcomes. Int. J. Radiat. Oncol. Biol. Phys. 88(5), 986-999 (2014).
22. Rosenberg SA, Robbins P, Restifo NP. Cancer immunotherapy. In: Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology(9th Edition). Rosenberg SA, Lawrence TS, Devita VT (Eds). Lippincott Williams & Wilkins, Philadelphia, USA, 333-344 (2011).
23. Miller AM, Pisa P. Tumor escape mechanisms in prostate cancer. Cancer Immunol. Immunother. 56, 81-87 (2007).
24. Finkelstein SE, Gabrilovich DI, Bui M et al. Combination of external beam radiation (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high risk soft tissue sarcoma patients. Int. J. Radiat. Oncol. Biol. Phys. 82, 924-932 (2012).
25. Gulley JL, Arlen PM, Bastian A et al. Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer. Clin. Cancer Res. 11, 3353-3362 (2005).
26. Okawa T, Kita M, Arai T et al. Phase II randomized clinical trial of LC9018 concurrently used with radiation in the treatment of carcinoma of the uterine cervix. Cancer 64, 1769-1776 (1989).
27. Chi KH, Liu SJ, Li CP et al. Combination of conformal radiotherapy and intratumoral injection of adoptive dendritic cell immunotherapy in refractory hepatoma. Immunotherapy 28, 129-135 (2005).
28. Seung SK, Curti BD, Crittenden M et al. Phase I study of stereotactic body radiotherapy and interleukin-2: tumor and immunological responses. Sci. Transl. Med. 4(137), 137ra74 (2012).
29. Kim YH, Gratzinger D, Harrison C et al. In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study. Blood 119(2), 355-362 (2011).
30. Lechleider RJ, Arlen PM, Tsang KY et al. Safety and immunologic response of a viral vaccine to PSA in combination with radiation therapy when metronomic-dose IL-2 is used as an adjuvant. Clin. Cancer Res. 14(16), 5284-5291 (2008).
31. Finkelstein SE, Trotti A, Rao N et al. The Florida Melanoma Trial I: a prospective multicenter Phase I/II trial of postoperative hypofractionated adjuvant radiotherapy with concurrent interferon-alfa-2b in the treatment of advanced stage III melanoma with long-term toxicity follow-up. Immunology doi:10.5402/2012/324235 (2012) (Epub ahead of print).
32. Hodi FS, O'Day SJ, McDermott DF et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363, 711-723 (2010).
33. Knisely JP, Yu JB, Flanigan J et al. Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival. J. Neurosurg. 117, 227-233 (2012).
34. Kiess AP, Wolchok JD, Barker CA et al. Ipilimumab and stereotactic radiosurgery for melanoma brain metastases. Int. J. Radiat. Oncol. Biol. Phys. 84, S115-S116 (2012).
35. Hiniker SM, Chen DS, Reddy S et al. A systemic complete response of metastatic melanoma to local radiation and immunotherapy. Transl. Oncol. 5, 404-407 (2012).